Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Hemofiltration Replacement Fluid of Sodium Citrate

Approval Number

国药准字HJ20210035

CompanyBaxter Holding BV

Registration Date

May 19, 2021

Drug Information

Generic Name

枸橼酸钠血滤置换液

Brand Name

瑞吉赛

Dosage Form

注射剂

Strength

5000ml

Drug Type

化学药品

Registration Date

May 19, 2021

Expiry Date

May 18, 2026

Company Information

Applicant Company

Company NameBaxter Holding BV

Company Address

Kobaltweg 49, 3542CE Utrecht, Netherlands

Manufacturing Company

Company NameBIEFFE MEDITAL SPA

Company Address

Via Stelvio 94-23035 Sondalo (SO), Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy